We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-7.29%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.56B
AUM Growth
-$331M
Cap. Flow
+$44.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
43.87%
Holding
254
New
54
Increased
34
Reduced
29
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 16.42%
2 Financials 14.11%
3 Consumer Discretionary 11.49%
4 Communication Services 8.06%
5 Utilities 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLTX icon
126
MoonLake Immunotherapeutics
MLTX
$1.49B
$1.49M 0.06%
150,000
QTEK
127
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$1.49M 0.06%
150,000
LJAQ
128
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
$1.48M 0.06%
150,000
HCC icon
129
Warrior Met Coal
HCC
$4.45B
$1.4M 0.05%
60,000
-49,000
-45% -$991K
SDC
130
CALL
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$1.34M 0.05%
+252,600
New +$1.57M
WGS icon
131
GeneDx Holdings
WGS
$2.08B
$1.31M 0.05%
5,222
PRVB
132
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.27M 0.05%
198,429
-100,000
-34% -$643K
HCAQ
133
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$1.19M 0.05%
120,000
CND.WS
134
DELISTED
Concord Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CND.WS
$1.17M 0.05%
662,100
+162,100
+32% +$301K
LILMW
135
DELISTED
Lilium N.V. Warrants
LILMW
$1.13M 0.04%
+500,000
New +$997K
ARDX icon
136
Ardelyx
ARDX
$1.21B
$1.12M 0.04%
848,405
-1,750,000
-67% -$4.67M
ACHV icon
137
Achieve Life Sciences
ACHV
$684M
$1.06M 0.04%
125,000
MRT icon
138
Marti Technologies
MRT
$154M
$1.04M 0.04%
+105,000
New +$1.03M
GSAT icon
139
Globalstar
GSAT
$10.7B
$1M 0.04%
39,905
-56,667
-59% -$1.39M
YARW
140
Yarrow Bioscience, Inc. Common Stock
YARW
$25.2M
$994K 0.04%
795
-20
-2% -$38.8K
EQRX
141
DELISTED
EQRx, Inc. Common Stock
EQRX
$992K 0.04%
+100,000
New +$1M
LITTU
142
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
$992K 0.04%
100,001
-399,999
-80% -$3.99M
GLTA.U
143
DELISTED
Galata Acquisition Corp. Units, each consisting of one class A ordinary share and one-half of one warrant
GLTA.U
$951K 0.04%
+95,000
New +$949K
GEF.B icon
144
Greif Class B
GEF.B
$4.23B
$772K 0.03%
11,910
CLLS
145
Cellectis
CLLS
$281M
$756K 0.03%
59,900
JOBY.WS icon
146
Joby Aviation Warrants
JOBY.WS
$215K
$737K 0.03%
+327,578
New +$701K
NKLA
147
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
$722K 0.03%
2,257
ACHR icon
148
Archer Aviation
ACHR
$3.97B
$710K 0.03%
+80,000
New +$726K
IAG icon
149
IAMGOLD
IAG
$9.18B
$678K 0.03%
300,000
CRC icon
150
California Resources
CRC
$4.56B
$665K 0.03%
16,218

Similar funds

683 Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, 683 Capital Management held 254 positions worth $2.56B, down 11% from $2.89B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

683 Capital Management's Q3 2021 filing shows 54 new, 34 increased, 29 reduced and 35 closed positions. Its largest new stake was Opendoor: 2,066,667 shares worth $41.1M. The largest sale was Joby Aviation, an estimated $54.3M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • 683 Capital Management's largest Q3 2021 buy was Opendoor: 2,066,667 shares worth $41.1M.
  • 683 Capital Management added most to Cardlytics in Q3 2021, an estimated $56.2M increase.
  • 683 Capital Management's biggest Q3 2021 reduction was Carvana, cutting an estimated $18.3M.
  • 683 Capital Management fully exited Joby Aviation in Q3 2021, selling an estimated $54.3M.
  • 683 Capital Management's ten largest holdings make up 44% of its $2.56B portfolio in Q3 2021.
  • 683 Capital Management opened 54 new positions and closed 35 in Q3 2021.
  • 683 Capital Management's portfolio value fell 11% quarter-over-quarter to $2.56B.

Based on 683 Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.